Sagent Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS
SAGENT PHARMS has seventy-seven approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Drugs and US Patents for Sagent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 204693-002 | Mar 7, 2018 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-003 | Nov 27, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms | LEUCOVORIN CALCIUM PRESERVATIVE FREE | leucovorin calcium | INJECTABLE;INJECTION | 200753-003 | Sep 6, 2012 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040888-001 | Jul 18, 2011 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090583-004 | Nov 27, 2015 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

